dc.contributor.advisor | Hansen, John-Bjarne | |
dc.contributor.author | Ellingsen, Trygve Sølberg | |
dc.date.accessioned | 2018-06-08T10:18:22Z | |
dc.date.available | 2018-06-08T10:18:22Z | |
dc.date.issued | 2018-06-11 | |
dc.description.abstract | Venous thromboembolism (VTE) is a collective term for deep vein thrombosis and pulmonary embolism. VTE is the third most common cardiovascular disease, causing significant morbidity and mortality. The incidence of VTE has been stable or slightly increasing during the last decades, affecting 1-2 per 1000 individuals each year. Up to half of all VTE patients have no obvious cause of the disease. Thus, identifying novel biomarkers and unraveling underlying disease mechanisms might help diminish the health burden of VTE. Red cell distribution width (RDW) is a measure of the variability of size of the circulating red blood cells. RDW increase due to various conditions that alter the bone marrow’s production of red blood cells, such as iron deficiency. Recent years, RDW has been associated with risk of several diseases. The first aim of this thesis was to investigate whether RDW is associated with future risk of VTE and mortality among VTE patients. Secondly, we aimed to investigate whether the association could be explained by underlying iron deficiency or intermediate development of other diseases.
All papers in this thesis use data from the Tromsø Study, a large population-based cohort study. Our study populations were recruited from the fourth survey. For paper I, subjects were followed from date of inclusion in 1994/95 through January 1, 2012. In paper III and IV, study participants were followed from date of inclusion through December 31, 2010. Paper II is a nested case-control study with cases and controls selected among participants in Tromsø 4. Validated events of VTE, cancer, myocardial infarction (MI) and stroke were registered throughout the study periods.
We found that RDW was associated with future risk of VTE and all-cause mortality among VTE-patients. The association could not be explained by underlying iron deficiency. Further, RDW was associated with future risk of cancer, but intermediate development of cancer, stroke or MI did not explain the association between RDW and VTE. | en_US |
dc.description.abstract | Venøs blodpropp eller venøs tromboembolisme (VTE) er en fellesbetegnelse på tilstandene dyp venetrombose og lungeemboli. VTE er verdens tredje vanligste hjerte- og karsykdom, og forårsaker betydelig morbiditet og mortalitet. Til tross for økt fokus på forebygging, har forekomsten vært stabil eller økende de siste tiårene. Hvert år rammes 1-2 av 1000 personer, og halvparten av de rammede har ingen åpenbar årsak. Nye bio- og risikomarkører kan bidra til bedre forståelse og forebygging av sykdommen, og kan dermed redusere de helsemessige konsekvensene. Graden av variasjon i størrelse på de røde blodcellene kan kvantifiseres som «Red Cell distribution Width» (RDW). RDW kan øke som en følge av ulike tilstander som påvirker beinmargens produksjon av røde blodceller, som for eksempel jernmangel. De siste årene har man funnet en sammenheng mellom RDW og risiko for flere sykdommer. Formålet med denne avhandlingen var å undersøke om RDW kan forutsi fremtidig risiko for VTE, samt dødelighet blant VTE-pasienter. Videre ønsket vi å undersøke om bakenforliggende jernmangel eller utvikling av andre sykdommer kunne forklare sammenhengen.
Alle artiklene i avhandlingen er basert på Tromsøundersøkelsen, som er en stor kohortestudie. Vi har benyttet data fra den fjerde undersøkelsen (Tromsø 4), som ble gjennomført i 1994-95. I den første artikkelen ble studiedeltakerne fulgt fra studiestart til og med 1. januar 2012. I den tredje og fjerde artikkelen ble deltakerne fulgt til og med 31. desember 2010. Den andre artikkelen er en nestet kasus-kontroll-studie med deltakere rekruttert fra Tromsø 4. Alle tilfeller av VTE, hjerteinfarkt, slag og kreft ble registret og validert gjennom studieperiodene.
Vi fant en sammenheng mellom høy RDW og økt risiko for fremtidig VTE, samt risiko for dødelighet blant VTE-pasienter. Sammenhengen kom ikke som en følge av jernmangel. Vi fant også en sammenheng mellom høy RDW og risiko for kreft, men hverken utvikling av kreft, hjerneslag eller hjerteinfarkt kunne forklare sammenhengen mellom RDW og VTE. | en_US |
dc.description.doctoraltype | ph.d. | en_US |
dc.description.popularabstract | Venous thromboembolism (VTE) is the formation of a blood clot in the veins. VTE is a serious disease affecting 1-2 per 1000 individuals each year. Novel biomarkers might help diminish the health burden of VTE. Red cell distribution width (RDW) is a measure of the variability of size of the red blood cells. Recent years, RDW has been associated with risk of several diseases, via unknown underlying mechanisms. The main aim of this thesis was to investigate whether RDW is associated with future risk of VTE and mortality among VTE patients, and whether underlying iron deficiency or intermediate development of other diseases may explain the association. Using data from the Tromsø Study, we found that RDW was associated with future risk of VTE. The association could not be explained by underlying iron deficiency. Further, RDW was associated with future risk of cancer, but intermediate development of cancer, stroke or myocardial infarction did not explain the association between RDW and VTE. | en_US |
dc.description.sponsorship | The MD/PhD program (Forskerlinja), UiT - the Arctic University of Norway
The Northern Norway Health Authority (Helse Nord) | en_US |
dc.description | Paper I of the thesis is not available in Munin.<br>Ellingsen, T.S., Lappegård, J., Skjelbakken, T., Brækkan, S.K. & Hansen, J.B. (2015). Red cell distribution width is associated with incident venous thromboembolism (VTE) and case-fatality after VTE in a general population. The manuscript version of this paper is available in Munin at <a href=http://hdl.handle.net/10037/7364>http://hdl.handle.net/10037/7364</a>. | en_US |
dc.identifier.uri | https://hdl.handle.net/10037/12848 | |
dc.language.iso | eng | en_US |
dc.publisher | UiT The Arctic University of Norway | en_US |
dc.publisher | UiT Norges arktiske universitet | en_US |
dc.rights.accessRights | openAccess | en_US |
dc.rights.holder | Copyright 2018 The Author(s) | |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/3.0 | en_US |
dc.rights | Attribution-NonCommercial-ShareAlike 3.0 Unported (CC BY-NC-SA 3.0) | en_US |
dc.subject | VDP::Medical disciplines: 700::Clinical medical disciplines: 750::Hematology: 775 | en_US |
dc.subject | VDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Hematologi: 775 | en_US |
dc.subject | VDP::Medical disciplines: 700::Health sciences: 800::Epidemiology medical and dental statistics: 803 | en_US |
dc.subject | VDP::Medisinske Fag: 700::Helsefag: 800::Epidemiologi medisinsk og odontologisk statistikk: 803 | en_US |
dc.subject | The Tromsø Study | |
dc.subject | Tromsøundersøkelsen | |
dc.title | Red cell distribution width and risk of venous thromboembolism | en_US |
dc.type | Doctoral thesis | en_US |
dc.type | Doktorgradsavhandling | en_US |